SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037398
Filing Date
2022-11-10
Accepted
2022-11-10 16:28:45
Documents
72
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pstx-10q_20220930.htm   iXBRL 10-Q 2852337
2 EX-10.1 pstx-ex101_92.htm EX-10.1 2854602
3 EX-31.1 pstx-ex311_7.htm EX-31.1 19073
4 EX-31.2 pstx-ex312_8.htm EX-31.2 19092
5 EX-32.1 pstx-ex321_10.htm EX-32.1 7829
6 EX-32.2 pstx-ex322_6.htm EX-32.2 7845
7 GRAPHIC ggagwvcoow0i000001.jpg GRAPHIC 731
8 GRAPHIC ggagwvcoow0i000002.jpg GRAPHIC 731
  Complete submission text file 0001564590-22-037398.txt   12000538

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA pstx-20220930.xsd EX-101.SCH 55764
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pstx-20220930_cal.xml EX-101.CAL 48765
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pstx-20220930_def.xml EX-101.DEF 185113
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstx-20220930_lab.xml EX-101.LAB 454080
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstx-20220930_pre.xml EX-101.PRE 332759
66 EXTRACTED XBRL INSTANCE DOCUMENT pstx-10q_20220930_htm.xml XML 1438588
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39376 | Film No.: 221377719
SIC: 2836 Biological Products, (No Diagnostic Substances)